Member Info for bobbust

If you are down here why did you not average down already.

It is still grossly undervalued

Our board knows these types of deals are out there.

They will have had offers but below what they are willing to accept.

My guess is a min of $10b for the lot.

Genmab as previously stated are paying 8b for a fraction of what we have.

Why do you think Martin is still buying!!!!.

Will continue to add here till the deal is done

I am also going.

Looking forward to chatting to them.

I presume they will do an update before the AGM .

If not I will have a long list of questions for them

Now the publicity drive will start.

They were waiting on this final sign off before they started a load of investor relation work

They have to proceed as normal even if they want to sell. All new information and progress should add to the final price

Each new step up is met with a bit of profit taking.

Main trend is still upward

Well I am surprised by this.

Unless FCM has sold a claim and they are going to have a stack more cash

Amazing

The major benefit could be reputation with this deal.

Validation by NCI!!!!

Others with deep pockets will be taking a look now

RMS out

"announces that Vulpes Testudo Fund, a fund closely associated with Martin Diggle, Non-Executive Director, has purchased 3,150,000 ordinary shares of 0.1p each ('Ordinary Shares') in the Company on 12 September 2025 at a price of 8.861 pence per share"

That was my question.

Not cash positive yet but grants will bridge the gap to when we are.

Should not need another raise

Its in the diary.

Beer would be good!!!

If and I know its a big if, but if all three anti bodies work Genmab is on the hook for $1,800M plus royalties

With a MC of £100m it would make sense for them to put an offer in for everything, buy the whole company.

The question is why not?

They know they would have to offer a lot more than the SP today but anything less than £2 a share is a bargain

Minimal discount!!!!

Guess what they need the money to spend to prove the asset

Its 7% dilution !!!!

Thats what they are on AIM for to raise capital.

If this drops I will be topping up

Deals will continue to be signed.

Looks like those saying chairman purchase would mean no deals for a while were incorrect.

100k at 8.74 is a buy

I think he is saying this deal is more lucrative than the market is giving them credit for

Undisclosed means the partner does not want commercially sensitive information being released.

They may not want to spook the market on how much it will add to there trial costs.

It could be significant in terms of our cash burn